• Subscribe
  • Advertise
  • Contact Us
June 16, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
HomeDiseases

Diseases

Diseases

UK’s ICR finds new combination therapy for colon cancer

February 7, 2018 Pharma News HQ 0

A study conducted by the ICR revealed that colon cancer can be treated by combining drugs able to block cancer growth and survival with those that can trigger cancer death. During the research, the scientists […]

Diseases

Sanofi sued over alleged dengue vaccine death

February 6, 2018 Pharma News HQ 0

The Public Attorney’s Office (PAO) in the Philippines has filed a lawsuit against Sanofi seeking compensation for the death of a 10-year-old girl allegedly caused by a vaccine manufactured by the drug company. The PAO […]

Diseases

NICE backs Roche’s Perjeta for breast cancer

February 1, 2018 Pharma News HQ 0

The guidelines follow a confidential commercial agreement for Perjeta (pertuzumab) agreed between NHS England and the drugmaker late last year, paving the pay for its move from the Cancer Drugs Fund (CDF) to the NHS’ […]

Diseases

‘Urgent action’ needed to accelerate antimicrobial resistance R&D

February 1, 2018 Pharma News HQ 0

The AMR Industry Alliance is a coalition of over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations that was formed to measure industry progress to curb antimicrobial resistance. The report, based on […]

Diseases

NHS plans to be first to eliminate hepatitis C

January 31, 2018 Pharma News HQ 0

It is hoped that the next round of procurement, which launches in February and is to be the single largest medicines procurement ever done by the NHS, will see new agreements drawn up with drug […]

Posts pagination

« 1 … 25 26 27 … 32 »



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0